CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- Open-market buys, last 90 days
- $757,691
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$757,691. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-30 | Levy Adam R. Chief Executive Officer | Sale | −1,000 | $2.22 | $2K | 368,284 |
| 2025-05-16 | Levy Adam R. Chief Executive Officer | Sale | −1,000 | $2.58 | $3K | 369,284 |
| 2025-05-12 | Henry Scott Robert Director | Sale 10b5-1 | −3,000 | $2.69 | $8K | 132,053 |
| 2025-04-10 | Henry Scott Robert Director | Sale 10b5-1 | −3,000 | $2.61 | $8K | 135,053 |
| 2025-04-01 | Levy Adam R. Chief Executive Officer | Sale 10b5-1 | −4,000 | $3.01 | $12K | 370,284 |
| 2025-03-10 | Henry Scott Robert Director | Sale 10b5-1 | −3,000 | $2.87 | $9K | 138,053 |
| 2025-03-03 | Levy Adam R. Chief Executive Officer | Sale 10b5-1 | −4,000 | $3.16 | $13K | 374,284 |
| 2025-02-12 | glassman steven mark Director | Grant or award | +2,500 | 156,655 | ||
| 2025-02-12 | Henry Scott Robert Director | Grant or award 10b5-1 | +2,500 | 141,053 | ||
| 2025-02-10 | Henry Scott Robert Director | Sale 10b5-1 | −3,000 | $3.27 | $10K | 138,553 |
| 2025-02-03 | Levy Adam R. Chief Executive Officer | Sale 10b5-1 | −4,000 | $3.64 | $15K | 378,284 |
| 2025-01-07 | Henry Scott Robert Director | Sale 10b5-1 | −3,000 | $3.37 | $10K | 141,553 |
| 2025-01-02 | Levy Adam R. Chief Executive Officer | Grant or award 10b5-1 | +26,116 | 386,284 | ||
| 2025-01-02 | Levy Adam R. Chief Executive Officer | Sale 10b5-1 | −4,000 | $3.96 | $16K | 382,284 |
| 2025-01-02 | Levy Adam R. Chief Executive Officer | Grant or award · Stock Options (right to buy) 10b5-1 | +150,000 | 150,000 | ||
| 2024-12-20 | Henry Scott Robert Director | Sale 10b5-1 | −3,000 | $4.64 | $14K | 144,553 |
| 2024-11-20 | glassman steven mark Director | Purchase | +9,090 | $2.75 | $25K | 154,155 |
| 2024-11-20 | glassman steven mark Director | Grant or award · Warrant to Purchase Common Stock | +4,545 | 4,545 | ||
| 2024-11-20 | Henry Scott Robert Director | Purchase | +1,818 | $2.75 | $5K | 147,553 |
| 2024-11-20 | Henry Scott Robert Director | Grant or award · Warrant to Purchase Common Stock | +909 | 909 |
Page 4 of 9 · 176 trades